About 1 300 reports

Figure ##: Reproductive Hormones and Proteins Tests - Pipeline Products by Segment

  • Hormone
  • Clinical Trial
  • World
  • Direct Sales
  • Milk Production

Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor ## or MSHR or MC##R) – Therapeutics Assessment

  • Pharmaceutical
  • Hormone
  • World
  • Drug Approval
  • Mortality Rate

Abstract: - Global Hormone Replacement Therapy (HRT) Market to Reach $10.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hormone Replacement Therapy (HRT) estimated at US$7.6 Billion in the year 2020, is projected to reach a revised size of US$10.6 Billion by 2027, growing at a CAGR of 4.8% over...

  • Hormone
  • World
  • China
  • United States

Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor ## or MSHR or MC##R) – Therapeutics Assessment

  • Hormone
  • Pharmaceutical
  • World
  • United States
  • Drug Approval
  • Labour Force

KEY FINDINGS The global hormone replacement therapy market is estimated to project a CAGR of 7.67% during the forecast period, 2021-2028. The awareness of post-menopausal issues, product launches by major players, and growing hormonal disorders drive market growth. MARKET INSIGHTS HRT (hormone...

  • Hormone
  • APAC
  • World
  • Drug Approval

Major players in the biosimilar hormones market are Teva Pharmaceutical, Gedeon Richter, Intas Pharmaceuticals, Biocon, Mylan, Sanofi, Sandoz (Novartis), LG Life Sciences, Ferring Pharmaceuticals and GC Pharma. The global biosimilar hormones market is expected to decline from $2.05 billion in 2019 to $1.94 billion in 2020 at a compound...

  • Hormone
  • World
  • Biosimilar Sales
  • Biologics Approval

Hormone Replacement Therapy Market Report Overview Hormone Replacement Therapy market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Hormone Replacement Therapy market types and applications. It is a focused study on Hormone Replacement Therapy...

  • Hormone
  • World
  • Health Provider Density

Hormone replacement therapy (HRT) is used for replenishing the hormones that are present in low levels in the human body. This treatment is particularly favourable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism. HRT is available in several forms such...

  • Hormone
  • World

Drugs For Hormonal Replacement Therapy Global Market Report 2020-30: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global drugs for hormonal replacement therapy market as it emerges from the Covid 19 shut down. Description: Where...

  • Human Growth Hormone
  • Marketing Research
  • In-Store Retail
  • Pharmacy
  • Infectious Disease
  • Endocrine Disease
  • Hormone
  • World

The North America hormone replacement therapy market reached a value of US$ 3.5 Billion in 2018. Hormone replacement therapy (HRT) is used for replenishing hormones that are present in low levels in the human body. This treatment is particularly favorable for patients who are experiencing growth hormone deficiency, women nearing menopause...

  • Hormone
  • North America

Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Estrogen, Human Growth), By Route Of Administration (Oral, Parenteral), By Type Of Disease, By Region, And Segment Forecasts, 2020 - 2027 The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027,...

  • Hormone
  • World

Follicle Stimulating Hormone Receptor (Follitropin Receptor or FSHR) - Drugs in Development, 2021 Summary Follicle Stimulating Hormone Receptor (Follitropin Receptor or FSHR) - Drugs in Development, 2021 provides in depth analysis on Follicle Stimulating Hormone Receptor (Follitropin Receptor or...

  • Hormone
  • Research And Development
  • Drug Development
  • World

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Hormone Refractory (Castration...

  • Prostate Cancer
  • Hormone
  • World

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the...

  • Prostate Cancer
  • Hormone
  • World

The ongoing clinical trial research report- “2019 Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer trials across the world. The report presents top level analysis...

  • Prostate Cancer
  • Clinical Trial
  • Hormone
  • World
  • APAC

The ongoing clinical trial research report- “2019 Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Ongoing Clinical Trials Study” analyzes the current scenario of all active Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer trials across the world. The report...

  • Prostate Cancer
  • Clinical Trial
  • Hormone
  • World
  • APAC

Protein Disulfide Isomerase (Prolyl 4 Hydroxylase Subunit Beta or Cellular Thyroid Hormone Binding Protein or p55 or P4HB or EC 5.3.4.1) - Drugs in Development, 2021 Summary Protein Disulfide Isomerase (Prolyl 4 Hydroxylase Subunit Beta or Cellular Thyroid Hormone Binding Protein or p55 or P4HB or...

  • Hormone
  • World

Figure ##. US Hormone Replacement Therapies Market Revenue and Forecasts to 2027 (US$ Mn)

  • Pharmacy
  • Hormone
  • Analgesic
  • United States
  • Use Of Prescription Drugs
  • Drug Approval

Thyroid Hormone Receptor Beta (Nuclear Receptor Subfamily 1 Group A Member 2 or c erbA 2 or c erbA Beta or ERBA2 or THRB) - Drugs in Development, 2021 Summary Thyroid Hormone Receptor Beta (Nuclear Receptor Subfamily 1 Group A Member 2 or c erbA 2 or c erbA Beta or ERBA2 or THRB) - Drugs in Development,...

  • Hormone
  • World

Abstract: - Global Endometriosis Drugs Market to Reach $2.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Endometriosis Drugs estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at aCAGR of 2.8% over the period 2020-2027. Hormone...

  • Genitourinary System Disease
  • Pharmaceutical
  • Hormone
  • Analgesic
  • World
  • China
  • United States

Thyroid Hormone Receptor Alpha (Nuclear Receptor Subfamily 1 Group A Member 1 or V erbA Related Protein 7 or c erbA 1 or c erbA Alpha or EAR7 or THRA) - Drugs in Development, 2021 Summary Thyroid Hormone Receptor Alpha (Nuclear Receptor Subfamily 1 Group A Member 1 or V erbA Related Protein 7 or...

  • Hormone
  • World

Abstract: - Global Male Hypogonadism Market to Reach $3.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Male Hypogonadism estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at aCAGR of 2.9% over the period 2020-2027. Testosterone...

  • Cancer Hormonal Therapy
  • Hormone
  • World
  • China
  • United States

Endocrine Test Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Endocrine Test market including the COVID-19 pandemic implications for Endocrine...

  • Infectious Disease
  • Polyclonal Antibody
  • Medical Biotechnology
  • Insulin
  • Hormone
  • Diagnostics
  • APAC
  • Central America

Compounded drugs for hormone replacement therapies (HRTs) has been leading the global compounding pharmacies market by therapeutic area.

  • Healthcare
  • Hormone
  • Diabetes
  • World
  • APAC
  • North America
  • Health Expenditure
  • Diabetes Prevalence

Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor ## or MSHR or MC##R) – Therapeutics Assessment

  • Hormone
  • World
  • Europe
  • Health Provider Density
  • Drug Approval

Adrenocorticotropic Hormone Receptor (Adrenocorticotropin Receptor or Melanocortin Receptor ## or ACTHR or MC##R) - Dormant Products

  • Hormone
  • Pharmaceutical
  • World
  • Drug Approval
  • Medicine Use

The Global Osteoporosis Drugs Market size is expected to reach $10.9 billion by 2026, rising at a market growth of 4.4% CAGR during the forecast period. Osteoporosis is defined as a medical condition that is characterized by low bone density and quality in humans. Bones are brittle in this medical state, which renders them more vulnerable...

  • Musculoskeletal Disorder
  • Hormone
  • World
  • Asia

## Hormone Replacement Therapies

  • Hormone
  • Infectious Disease
  • APAC
  • Europe
  • World
  • Health Expenditure
  • Drug Approval

Small Molecule to Antagonize Adrenal Corticotropic Hormone Receptor for Cushing Disease and Congenital Adrenal Hyperplasia – Drug Profile

  • Therapy
  • Drug Development
  • Hormone
  • Cancer
  • Pharmaceutical
  • World
  • Pharmaceutical Registrations

Chart ##: Luteinizing Hormone Releasing Hormone Analogue Import by Drugs Classification

  • Prostate Cancer
  • Hormone
  • China
  • Industrial Production
  • Labour Force